Equities

Zhejiang Hisun Biomaterials Co Ltd

688203:SHH

Zhejiang Hisun Biomaterials Co Ltd

Actions
Basic MaterialsChemicals
  • Price (CNY)9.77
  • Today's Change-0.31 / -3.08%
  • Shares traded1.45m
  • 1 Year change-33.49%
  • Beta--
Data delayed at least 15 minutes, as of May 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zhejiang Hisun Biomaterials Co Ltd is a China-based company principally engaged in the research and development, production and sales of Polylactide (PLA). The Company's main products include polylactic acid in resin form, which can be divided into pure polylactic acid and compound modified polylactic acid. The Company is also engaged in the sale of PLA primary products in the form of powders, films, non-woven fabrics, and others.

  • Revenue in CNY (TTM)802.46m
  • Net income in CNY46.30m
  • Incorporated2004
  • Employees383.00
  • Location
    Zhejiang Hisun Biomaterials Co LtdNo. 188 Taizhouwan AvenueTaizhouwan New DistrictTaizhou 318000ChinaCHN
  • Phone+86 57 688931556
  • Fax+86 57 688827723
  • Websitehttp://www.hisunplas.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhejiang Hisun Biomaterials Co Ltd802.46m46.30m2.04bn383.0044.131.37--2.550.22840.22843.967.340.40055.2419.522,095,207.002.31--2.84--12.78--5.77--2.10--0.2166--24.43---7.41------
Shaanxi Meibang Pharmaceuticl Grp Co Ltd666.41m32.72m2.06bn939.0062.901.78--3.090.24210.24214.938.570.42761.622.31709,697.402.108.612.5412.5729.9136.784.9113.692.31--0.059615.66-22.859.77-60.33-0.605142.34--
Shandong Cynda Chemical Co Ltd2.42bn-156.07m2.08bn2.18k--1.04--0.8572-0.3718-0.37185.624.580.68282.676.931,112,224.00-4.346.37-7.219.168.4723.74-6.367.480.8941--0.282535.64-20.588.70-125.68---10.16--
Argus Shanghai Textile Chemicals Co Ltd799.55m51.24m2.16bn517.0041.621.80--2.710.27170.27174.176.300.47771.463.101,546,523.002.924.203.945.2829.0828.806.117.481.0511.670.141335.060.7462-3.836.18-19.4413.51-15.40
Suli Co Ltd1.89bn-5.18m2.19bn1.58k--0.8857--1.16-0.0269-0.026910.4313.760.3494.616.121,197,981.00-0.19776.90-0.291410.6111.5223.64-0.566512.221.70--0.357232.42-37.843.54-93.63-42.2336.47-39.16
Data as of May 23 2024. Currency figures normalised to Zhejiang Hisun Biomaterials Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

10.78%Per cent of shares held by top holders
HolderShares% Held
Penghua Fund Management Co., Ltd.as of 31 Dec 20233.67m7.61%
Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 20231.05m2.17%
Gfund Management Co., Ltd.as of 31 Dec 2023364.90k0.76%
Taikang Asset Management Co. Ltd.as of 31 Dec 202330.00k0.06%
Minsheng Royal Fund Management Co., Ltd.as of 31 Dec 202316.07k0.03%
Xingyin Fund Management Co., Ltd.as of 31 Dec 202315.40k0.03%
Guotai Asset Management Co., Ltd.as of 31 Dec 202315.09k0.03%
CR Yuanta Fund Management Co.,Ltdas of 31 Dec 202314.80k0.03%
Bank of China Investment Management Co., Ltd.as of 31 Dec 202314.72k0.03%
China Asset Management Co., Ltd.as of 30 Jun 202314.30k0.03%
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.